Therapeutic effect of exogenous bone marrow-derived mesenchymal stem cell transplantation on silicosis via paracrine mechanisms in rats

Molecular Medicine Reports

Volumn 8, Issue 3, 2013, Pages 741-746

  Zhao, Man Man ^a   Cui, Jian Zhong ^b   Cui, Ying ^b   Li, Ran ^a   Tian, Yan Xia ^a   Song, Si Xin ^c   Zhang, Juan ^a   Gao, Jun Ling ^a  

^a HEBEI UNITED UNIVERSITY   (China)

^b Tangshan Worker's Hospital   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

BMSCs; IL 1; IL 1RA; Silicosis; SRY; TNF

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TESTIS DETERMINING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; RAT; SILICOSIS; WESTERN BLOTTING;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; FEMALE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PARACRINE COMMUNICATION; RATS; RATS, SPRAGUE-DAWLEY; SEX-DETERMINING REGION Y PROTEIN; SILICOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84881180431     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1580     Document Type: Article

References (31)

1. Rimal B, Greenberg AK and Rom WN: Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med 11: 169-173, 2005.
2. Herzog EL, Chai L and Krause DS: Plasticity of marrow-derived stem cells. Blood 102: 3483-3493, 2003.
3. Nishida H, Nakayama M, Tanaka H, et al: Safety of autologous bone marrow stromal cell transplantation in dogs with acute spinal cord injury. Vet Surg 41: 437-442, 2012.
4. Osanai T, Kuroda S, Sugiyama T, et al: Therapeutic effects of intra-arterial delivery of bone marrow stromal cells in traumatic brain injury of rats - in vivo cell tracking study by near-infrared fluorescence imaging. Neurosurgery 70: 435-444, 2012.
5. Zhao L, Feng Z, Hu B, Chi X and Jiao S: Ex vivo-expanded bone marrow mesenchymal stem cells facilitate recovery from chemically induced acute liver damage. Hepatogastroenterology 59: 2389-2394, 2012.
6. Islam MN, Das SR, Emin MT, et al: Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 18: 759-765, 2012.
7. Luan Y, Zhang X, Kong F, Cheng GH, Qi TG and Zhang ZH: Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism. Int Immunopharmacol 14: 432-437, 2012.
8. Aslam M, Baveja R, Liang OD, et al: Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 180: 1122-1130, 2009.
9. Ortiz LA, Gambelli F, McBride C, et al: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100: 8407-8411, 2003.
10. Luan Y, Zhang ZH, Wei DE, et al: Implantation of mesenchymal stem cells improves right ventricular impairments caused by experimental pulmonary hypertension. Am J Med Sci 343: 402-406, 2012.
11. Rojas M, Xu J, Woods CR, et al: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33: 145-152, 2005.
12. Nemeth K, Keane-Myers A, Brown JM, et al: Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 107: 5652-5657, 2010.
13. Wang PP, Xie DY, Liang XJ, et al: HGF and direct mesenchymal stem cells contact synergize to inhibit hepatic stellate cells activation through TLR4/NF-kB pathway. PLoS One 7: e43408, 2012.
14. Jin P, Zhang X, Wu Y, et al: Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplant Proc 42: 2745-2752, 2010.
15. Xu M, Uemura R, Dai Y, Wang Y, Pasha Z and Ashraf M: In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol 42: 441-448, 2007.
16. Mezey E: The therapeutic potential of bone marrow-derived stromal cells. J Cell Biochem 112: 2683-2687, 2011.
17. Reis LA, Borges FT, Simões MJ, Borges AA, Sinigaglia-Coimbra R and Schor N: Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. PLoS One 7: e44092, 2012.
18. Bakondi B, Shimada IS, Perry A, et al: CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke. Mol Ther 17: 1938-1947, 2009.
19. Burdon TJ, Paul A, Noiseux N, Prakash S and Shum-Tim D: Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Bone Marrow Res 2011: Dec 6 2010 (Epub ahead of print).
20. Arend WP: Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 88: 1445-1451, 1991.
21. Ortiz LA, Dutreil M, Fattman C, et al: Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104: 11002-11007, 2007.
22. Smajilagić A, Aljičević M, Redžić A, Filipović S and Lagumdžija A: Rat bone marrow stem cells isolation and culture as a bone formative experimental system. Bosn J Basic Med Sci 13: 27-30, 2013.
23. Abkowitz JL, Robinson AE, Kale S, Long MW and Chen J: Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood 102: 1249-1253, 2003.
24. Kinnaird T, Stabile E, Burnett MS, et al: Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549, 2004.
25. Nagaya N, Kangawa K, Itoh T, et al: Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112: 1128-1135, 2005.
26. Sharma RI and Snedeker JG: Paracrine interactions between mesenchymal stem cells affect substrate driven differentiation toward tendon and bone phenotypes. PLoS One 7: e31504, 2012.
27. Krasnodembskaya A, Song Y, Fang X, et al: Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 28: 2229-2238, 2010.
28. Zhang K and Phan SH: Cytokines and pulmonary fibrosis. Biol Signals 5: 232-239, 1996.
29. Kolb M, Margetts PJ, Anthony DC, Pitossi F and Gauldie J: Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107: 1529-1536, 2001.
30. Zhang Y, Lee TC, Guillemin B, Yu MC and Rom WN: Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 150: 4188-4196, 1993.
31. Piguet PF, Vesin C, Grau GE and Thompson RC: Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5: 57-61, 1993.